CA2224412A1 - Composition a base d'un compose modulant la reactivite des fibres nerveuses - Google Patents

Composition a base d'un compose modulant la reactivite des fibres nerveuses

Info

Publication number
CA2224412A1
CA2224412A1 CA002224412A CA2224412A CA2224412A1 CA 2224412 A1 CA2224412 A1 CA 2224412A1 CA 002224412 A CA002224412 A CA 002224412A CA 2224412 A CA2224412 A CA 2224412A CA 2224412 A1 CA2224412 A1 CA 2224412A1
Authority
CA
Canada
Prior art keywords
composition containing
modulating compound
nerve fibre
reactivity
fibre reactivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002224412A
Other languages
English (en)
Other versions
CA2224412C (fr
Inventor
Josiane Allec
Karen Ctorza
Anne-Emmanuelle Guise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2224412A1 publication Critical patent/CA2224412A1/fr
Application granted granted Critical
Publication of CA2224412C publication Critical patent/CA2224412C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une nouvelle composition aqueuse à base d'un composé modulant la réactivité des fibres nerveuses. Elle concerne plus particulièrement une composition pharmaceutique à usage topique sur un corps humain ou animal destinée à anesthésier la peau ou les muqueuses ou à traiter un prurit.
CA002224412A 1996-05-06 1997-05-06 Composition a base d'un compose modulant la reactivite des fibres nerveuses Expired - Fee Related CA2224412C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9605641A FR2748207B1 (fr) 1996-05-06 1996-05-06 Composition a base d'un compose modulant la reactivite des fibres nerveuses
FR96/05641 1996-05-06
PCT/FR1997/000810 WO1997041893A1 (fr) 1996-05-06 1997-05-06 Composition a base d'un compose modulant la reactivite des fibres nerveuses

Publications (2)

Publication Number Publication Date
CA2224412A1 true CA2224412A1 (fr) 1997-11-13
CA2224412C CA2224412C (fr) 2003-08-05

Family

ID=9491871

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002224412A Expired - Fee Related CA2224412C (fr) 1996-05-06 1997-05-06 Composition a base d'un compose modulant la reactivite des fibres nerveuses

Country Status (9)

Country Link
US (1) US6297290B2 (fr)
EP (1) EP0841948A1 (fr)
JP (1) JPH10510851A (fr)
CN (1) CN1197395A (fr)
AU (1) AU704772B2 (fr)
BR (1) BR9702241A (fr)
CA (1) CA2224412C (fr)
FR (1) FR2748207B1 (fr)
WO (1) WO1997041893A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2569155A1 (fr) 2004-06-02 2005-12-15 Sri International Formulations contenant un casaicinoide, un anesthesiant local et/ou un agent antipruritique pour le traitement de la douleur
CA2664396A1 (fr) * 2006-09-29 2008-04-10 Idenix Pharmaceuticals, Inc. Phosphoindoles enantiomeriquement purs utilisables en tant qu'inhibiteurs du vih
CA2696632C (fr) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. Formulations anesthesiques locales a concentration elevee
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
CA2774993A1 (fr) * 2008-09-26 2010-04-01 Suzana Hillhouse Dispositif et procede d'administration transdermique
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
CA2835595C (fr) 2011-05-10 2019-02-12 Itochu Chemical Frontier Corporation Timbre non aqueux
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
HUE039266T2 (hu) 2011-09-27 2018-12-28 Itochu Chemical Frontier Corp Nem-vizes tapasz
JP2021511113A (ja) * 2018-01-18 2021-05-06 ゾエティス・ブルームヒル・アイピー・リミテッド 乾乳牛のウシ乳房炎予防における内部ティートシールおよびその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO86590B1 (ro) * 1983-04-15 1985-05-01 Institutul De Medicina Si Farmacie Gel anestezic
JPS63201118A (ja) 1987-02-16 1988-08-19 Kao Corp 鎮痒剤
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
SE9202128D0 (sv) 1992-07-09 1992-07-09 Astra Ab Precipitation of one or more active compounds in situ

Also Published As

Publication number Publication date
EP0841948A1 (fr) 1998-05-20
FR2748207A1 (fr) 1997-11-07
CA2224412C (fr) 2003-08-05
US20010014349A1 (en) 2001-08-16
CN1197395A (zh) 1998-10-28
AU704772B2 (en) 1999-05-06
BR9702241A (pt) 1999-02-17
AU2902497A (en) 1997-11-26
FR2748207B1 (fr) 1998-06-12
US6297290B2 (en) 2001-10-02
JPH10510851A (ja) 1998-10-20
WO1997041893A1 (fr) 1997-11-13

Similar Documents

Publication Publication Date Title
BR9803596A (pt) Derivados do resorcinol.
CA2210848A1 (fr) Utilisation de derives de la melatonine pour la depigmentation de la peau et compositions les comprenant
CR9879A (es) Moduladores de ccr5 (divisional de la solicitud n° 6392)
CA2224412A1 (fr) Composition a base d'un compose modulant la reactivite des fibres nerveuses
CA2356310A1 (fr) Preparations externes contenant un medicament de base
BR9804437A (pt) Compostos para a osteoporose
BR9712491A (pt) Composições cosméticas
MA26729A1 (fr) Modulateurs nouveaux des recepteurs de glucocorticoides, procede pour leur preparation et compositions pharmaceutiques les contenant
BR9812371A (pt) Tratamento de distúrbio de conduta
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
BR9809111A (pt) Novos intermediários e processo para sua preparação
BR9913457A (pt) Neuroproteção
FR2809004B1 (fr) Utilisation de l'acide ellagique comme agent cosmetique anti-pollution
ATE83376T1 (de) Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
BRPI0408601A (pt) compostos com ação nootrópica, sua preparação, composições farmacêuticas os contendo, e seu uso
BR9808303A (pt) O uso de levobupivacaìna na cirurgia facial
BR0009211A (pt) Derivados de resorcinol
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
MA26726A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
CA2374154A1 (fr) Utilisations de derives de polyaminoacide comme agent hydratant, et compositions cosmetique ou pharmaceutique les comprenant
ES2154692T3 (es) Dihidrofarnesal.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed